MedKoo Cat#: 465424 | Name: VGD020

Description:

WARNING: This product is for research use only, not for human or veterinary use.

VGD020 is a CD4 and sortilin inhibitor. It displayed activity for sortilin down-modulation and reduction of progranulin-induced breast cancer stem cell propagation.

Chemical Structure

VGD020
VGD020
CAS#1322645-32-8 (free base)

Theoretical Analysis

MedKoo Cat#: 465424

Name: VGD020

CAS#: 1322645-32-8 (free base)

Chemical Formula: C31H45N3O5S2

Exact Mass: 603.2801

Molecular Weight: 603.84

Elemental Analysis: C, 61.66; H, 7.51; N, 6.96; O, 13.25; S, 10.62

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
1322645-32-8 (free base) 1322646-07-0 (HCl)
Synonym
VGD020; VGD 020; VGD-020;
IUPAC/Chemical Name
9-(cyclohexylmethyl)-1-((4-methoxyphenyl)sulfonyl)-3-methylene-5-tosyl-1,5,9-triazacyclododecane
InChi Key
IADINMLQCKJBSG-UHFFFAOYSA-N
InChi Code
InChI=1S/C31H45N3O5S2/c1-26-11-15-30(16-12-26)40(35,36)33-21-7-19-32(25-28-9-5-4-6-10-28)20-8-22-34(24-27(2)23-33)41(37,38)31-17-13-29(39-3)14-18-31/h11-18,28H,2,4-10,19-25H2,1,3H3
SMILES Code
C=C1CN(S(=O)(C2=CC=C(C)C=C2)=O)CCCN(CCCN(S(=O)(C3=CC=C(OC)C=C3)=O)C1)CC4CCCCC4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 603.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Berger K, Pauwels E, Parkinson G, Landberg G, Le T, Demillo VG, Lumangtad LA, Jones DE, Islam MA, Olsen R, Kapri T, Intasiri A, Vermeire K, Rhost S, Bell TW. Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds. J Med Chem. 2021 Aug 24. doi: 10.1021/acs.jmedchem.1c00943. Epub ahead of print. PMID: 34428050. 2: Ali R, Anugu S, Chawla R, Demillo VG, Goulinet-Mateo F, Gyawali S, Hamal S, Jones DE, Lamprecht K, Le T, Lumangtad LA, Pflug NC, Sama A, Scarbrough ED, Bell TW. Tsuji-Trost Cyclization of Disulfonamides: Synthesis of 12-Membered, 11-Membered, and Pyridine-Fused Macrocyclic Triamines. ACS Omega. 2019 Jan 31;4(1):1254-1264. doi: 10.1021/acsomega.8b02555. Epub 2019 Jan 15. PMID: 30729225; PMCID: PMC6356871. 3: Demillo VG, Goulinet-Mateo F, Kim J, Schols D, Vermeire K, Bell TW. Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents. J Med Chem. 2011 Aug 25;54(16):5712-21. doi: 10.1021/jm2002603. Epub 2011 Jul 29. PMID: 21800875.